SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $135,279 | -42.6% | 1,116 | -50.2% | 0.01% | +20.0% |
Q2 2023 | $235,612 | +40876.0% | 2,240 | +37233.3% | 0.01% | – |
Q1 2023 | $575 | +2638.1% | 6 | -97.3% | 0.00% | -100.0% |
Q4 2022 | $21 | -99.9% | 219 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $21,000 | +950.0% | 219 | +1052.6% | 0.00% | – |
Q2 2022 | $2,000 | -66.7% | 19 | -59.6% | 0.00% | – |
Q1 2022 | $6,000 | +50.0% | 47 | +67.9% | 0.00% | – |
Q4 2021 | $4,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | – | 28 | +2700.0% | 0.00% | – |
Q2 2021 | $0 | – | 1 | – | 0.00% | – |
Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 9 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 9 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q3 2019 | $38,000 | +1800.0% | 500 | +4445.5% | 0.00% | – |
Q1 2019 | $2,000 | -97.5% | 11 | -98.5% | 0.00% | -100.0% |
Q4 2018 | $80,000 | -70.0% | 742 | -55.1% | 0.01% | -54.5% |
Q3 2018 | $267,000 | +71.2% | 1,654 | +40.2% | 0.01% | +57.1% |
Q2 2018 | $156,000 | +92.6% | 1,180 | -18.7% | 0.01% | +75.0% |
Q1 2018 | $81,000 | 0.0% | 1,451 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $81,000 | +2.5% | 1,451 | -16.2% | 0.00% | +33.3% |
Q3 2017 | $79,000 | +54.9% | 1,732 | +13.9% | 0.00% | +50.0% |
Q2 2017 | $51,000 | +112.5% | 1,520 | +88.8% | 0.00% | +100.0% |
Q1 2017 | $24,000 | -38.5% | 805 | -43.3% | 0.00% | -50.0% |
Q4 2016 | $39,000 | -69.3% | 1,421 | -31.4% | 0.00% | -71.4% |
Q3 2016 | $127,000 | +64.9% | 2,071 | -48.9% | 0.01% | +75.0% |
Q2 2016 | $77,000 | +3750.0% | 4,050 | +36718.2% | 0.00% | – |
Q1 2016 | $2,000 | -99.5% | 11 | -99.9% | 0.00% | -100.0% |
Q4 2015 | $426,000 | – | 11,040 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |